U.S. Thyroid Cancer Diagnostics Market (2025 - 2033) Size, Share & Trends Analysis Report By Cancer (Papillary Carcinoma, Follicular Carcinoma), By Technique (Imaging, Biopsy), By End Use, By Region, And Segment Forecasts
- Report Summary
- Table of Contents
- Segmentation
- Methodology
- Download FREE Sample
-
Download Sample Report
Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Cancer
1.2.2. Technique
1.2.3. End Use
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased Database
1.4.2. GVR’s Internal Database
1.4.3. Secondary Sources
1.4.4. Primary Research
1.5. Information or Data Analysis
1.5.1. Data Analysis Models
1.6. Market Formulation & Validation
1.7. Model Details
1.8. List of Secondary Sources
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Cancer Outlook
2.2.2. Technique Outlook
2.2.3. End Use Outlook
2.2.4. Regional Outlook
2.3. Competitive Insights
Chapter 3. U.S. Thyroid Cancer Diagnostics Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. U.S. Thyroid Cancer Diagnostics Market Analysis Tools
3.3.1. Industry Analysis – Porter’s Five Forces Analysis
3.3.1.1. Supplier Power
3.3.1.2. Buyer Power
3.3.1.3. Substitution Threat
3.3.1.4. Threat of New Entrants
3.3.1.5. Competitive Rivalry
3.3.2. PESTLE Analysis
3.3.2.1. Political Landscape
3.3.2.2. Technological Landscape
3.3.2.3. Economic Landscape
Chapter 4. U.S. Thyroid Cancer Diagnostics Market: Cancer Business Analysis
4.1. Cancer Segment Dashboard
4.2. Thyroid Cancer Diagnostics Market: Cancer Movement Analysis
4.3. U.S. Thyroid Cancer Diagnostics Market Size & Trend Analysis, By Cancer, 2021 to 2033 (USD Million)
4.4. Papillary carcinoma
4.4.1. Market Estimates and Forecasts 2021 to 2033 (USD Million)
4.5. Follicular carcinoma
4.5.1. Market Estimates and Forecasts 2021 to 2033 (USD Million)
4.6. Others
4.6.1. Market Estimates and Forecasts 2021 to 2033 (USD Million)
Chapter 5. U.S. Thyroid Cancer Diagnostics Market: Technique Business Analysis
5.1. Technique Segment Dashboard
5.2. Thyroid Cancer Diagnostics Market: Technique Movement Analysis
5.3. U.S. Thyroid Cancer Diagnostics Market Size & Trend Analysis, By Technique, 2021 to 2033 (USD Million)
5.4. Blood Test
5.4.1. Market Estimates and Forecasts 2021 to 2033 (USD Million)
5.5. Imaging
5.5.1. Market Estimates and Forecasts 2021 to 2033 (USD Million)
5.6. Biopsy
5.6.1. Market Estimates and Forecasts 2021 to 2033 (USD Million)
5.7. Others
5.7.1. Market Estimates and Forecasts 2021 to 2033 (USD Million)
Chapter 6. U.S. Thyroid Cancer Diagnostics Market: End Use Business Analysis
6.1. End Use Segment Dashboard
6.2. Thyroid Cancer Diagnostics Market: End Use Movement Analysis
6.3. U.S. Thyroid Cancer Diagnostics Market Size & Trend Analysis, By End Use, 2021 to 2033 (USD Million)
6.4. Hospital Laboratories
6.4.1. Market Estimates and Forecasts 2021 to 2033 (USD Million)
6.5. Cancer Diagnostic Centers
6.5.1. Market Estimates and Forecasts 2021 to 2033 (USD Million)
6.6. Research Institutes
6.6.1. Market Estimates and Forecasts 2021 to 2033 (USD Million)
6.7. Others
6.7.1. Market Estimates and Forecasts 2021 to 2033 (USD Million)
Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.2. Company/Competition Categorization
7.3. Vendor Landscape
7.3.1. Key Company Heat Map Analysis, 2024
7.4. Company Profiles
7.4.1. Abbott
7.4.1.1. Company Overview
7.4.1.2. Financial Performance
7.4.1.3. Product Benchmarking
7.4.1.4. Strategic Initiatives
7.4.2. F.Hoffmann-La Roche Ltd.
7.4.2.1. Company Overview
7.4.2.2. Financial Performance
7.4.2.3. Product Benchmarking
7.4.2.4. Strategic Initiatives
7.4.3. Thermo Fisher Scientific, Inc.
7.4.3.1. Company Overview
7.4.3.2. Financial Performance
7.4.3.3. Product Benchmarking
7.4.3.4. Strategic Initiatives
7.4.4. Siemens Healthcare GmbH
7.4.4.1. Company Overview
7.4.4.2. Financial Performance
7.4.4.3. Product Benchmarking
7.4.4.4. Strategic Initiatives
7.4.5. Bio-Rad Laboratories, Inc.
7.4.5.1. Company Overview
7.4.5.2. Financial Performance
7.4.5.3. Product Benchmarking
7.4.5.4. Strategic Initiatives
7.4.6. GE HealthCare
7.4.6.1. Company Overview
7.4.6.2. Financial Performance
7.4.6.3. Product Benchmarking
7.4.6.4. Strategic Initiatives
7.4.7. Hologic, Inc.
7.4.7.1. Company Overview
7.4.7.2. Financial Performance
7.4.7.3. Product Benchmarking
7.4.7.4. Strategic Initiatives
7.4.8. Koninklijke Philips N.V.
7.4.8.1. Company Overview
7.4.8.2. Financial Performance
7.4.8.3. Product Benchmarking
7.4.8.4. Strategic Initiatives
7.4.9. Toshiba Corporation
7.4.9.1. Company Overview
7.4.9.2. Financial Performance
7.4.9.3. Product Benchmarking
7.4.9.4. Strategic Initiatives
7.4.10. Agilent Technologies, Inc.
7.4.10.1. Company Overview
7.4.10.2. Financial Performance
7.4.10.3. Product Benchmarking
7.4.10.4. Strategic Initiatives
7.4.11. Illumina, Inc.
7.4.11.1. Company Overview
7.4.11.2. Financial Performance
7.4.11.3. Product Benchmarking
7.4.11.4. Strategic Initiatives
List of Tables
Table 1 List Of Abbreviations
Table 2 U.S. Thyroid Cancer Diagnostics Market, By Cancer, 2021 - 2033 (USD Million)
Table 3 U.S. Thyroid Cancer Diagnostics Market, By Technique, 2021 - 2033 (USD Million)
Table 4 U.S. Thyroid Cancer Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
List of Figures
Fig. 1 Market Research Process
Fig. 2 Data Triangulation Techniques
Fig. 3 Primary Research Pattern
Fig. 4 Primary Interviews
Fig. 5 Market Research Approaches
Fig. 6 Value-Chain-Based Sizing & Forecasting
Fig. 7 QFD Modeling for Market Share Assessment
Fig. 8 Market Formulation & Validation
Fig. 9 Thyroid Cancer Diagnostics Market: Market Outlook
Fig. 10 Thyroid Cancer Diagnostics Competitive Insights
Fig. 11 Parent Market Outlook
Fig. 12 Related/Ancillary Market Outlook
Fig. 13 Penetration and Growth Prospect Mapping
Fig. 14 Industry Value Chain Analysis
Fig. 15 Thyroid Cancer Diagnostics Market Driver Impact
Fig. 16 Thyroid Cancer Diagnostics Market Restraint Impact
Fig. 17 Thyroid Cancer Diagnostics Market Strategic Initiatives Analysis
Fig. 18 Thyroid Cancer Diagnostics Market: Cancer Movement Analysis
Fig. 19 Thyroid Cancer Diagnostics Market: Cancer Outlook and Key Takeaways
Fig. 20 Papillary Carcinoma Market Estimates and Forecast, 2021 - 2033
Fig. 21 Follicular Carcinoma Market Estimates and Forecast, 2021 - 2033
Fig. 22 Others Market Estimates and Forecast, 2021 - 2033
Fig. 23 Thyroid Cancer Diagnostics Market: Technique Movement Analysis
Fig. 24 Thyroid Cancer Diagnostics Market: Technique Outlook and Key Takeaways
Fig. 25 Blood Test Market Estimates and Forecast, 2021 - 2033
Fig. 26 Imaging Market Estimates and Forecast, 2021 - 2033
Fig. 27 Biopsy Market Estimates and Forecast, 2021 - 2033
Fig. 28 Others Market Estimates and Forecast, 2021 - 2033
Fig. 29 Thyroid Cancer Diagnostics Market: End Use Movement Analysis
Fig. 30 Thyroid Cancer Diagnostics Market: End Use Outlook and Key Takeaways
Fig. 31 Hospital Laboratories Market Estimates and Forecasts, 2021 - 2033
Fig. 32 Cancer Diagnostic Centers Market Estimates and Forecasts, 2021 - 2033
Fig. 33 Research Institutes Market Estimates and Forecasts, 2021 - 2033
Fig. 34 Others Market Estimates and Forecasts, 2021 - 2033
Fig. 35 U.S. Market Estimates and Forecasts, 2021 - 2033
Get Free Sample Report
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
ISO 9001:2015 & 27001:2022 Certified
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
Trusted market insights - try a free sample
See how our reports are structured and why industry leaders rely on Grand View Research. Get a free sample or ask us to tailor this report to your needs.
